Home › Peripheral Arterial Disease › New Jersey
Peripheral Arterial Disease clinical trials in New Jersey
6 studies for Peripheral Arterial Disease are looking for participants at sites in New Jersey.
EVERO Drug-coated Balloon (DCB) Randomized Trial
- Cooper University Hospital, Camden
Recruiting
Ages 18 and older · All sexes · Updated Sep 29, 2026 · NCT07144150Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
- Hypertension & Nephrology Association, Eatontown
- New Jersey Kidney Care, Jersey City
RecruitingPhase 2/3
Ages 18 and older · All sexes · Updated Sep 21, 2026 · NCT05485961The Golazo® Peripheral Atherectomy System for a Safe and Effective Atherectomy (GREAT Trial)
- Advanced Heart and Vascular Institute, Flemington
Recruiting
Ages 18 and older · All sexes · Updated Aug 27, 2026 · NCT06321575The THOR IDE Study
- Deborah Heart and Lung Center, Browns Mills
- Heart and Vascular Institute of Central Jersey, New Brunswick
- Atlantic Medical Imaging of New jersey, Vineland
Recruiting
Ages 18 and older · All sexes · Updated Jun 11, 2026 · NCT05916950Serranator POINT FORCE Registry
- Atlantic Medical Imaging, Brick
- Virtua Health, Marlton
RecruitingObservational study
Ages 18 and older · All sexes · Updated May 7, 2026 · NCT06687590Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk
- Rutgers University, Newark
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Mar 24, 2026 · NCT04774159From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.